Tissue leptin levels in patients with breast cancer

Journal of B.U.ON.

Volumn 15, Issue 2, 2010, Pages 369-372

  Karaduman, M ^a   Bilici, Ahmet ^b   Ozet, A ^c   Sengul, A ^c   Musabak, U ^c   Alomeroglu, M ^d  

^a ETIMESGUT MILITARY HOSPITAL   (Turkey)

^b DR LUTFI KIRDAR KARTAL EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^c GULHANE SCHOOL OF MEDICINE   (Turkey)

^d DIYARBAKIR MILITARY HOSPITAL   (Turkey)

Author keywords

Breast cancer; Cancer tissue; Leptin; Normal breast tissue; Prognostic factor

Indexed keywords

AROMATASE INHIBITOR; CA 15-3 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; LEPTIN; PROGESTERONE RECEPTOR; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MENOPAUSE; TISSUE LEVEL; TUMOR VOLUME;

ADULT; AGED; BLOOD GLUCOSE; BODY MASS INDEX; BREAST NEOPLASMS; CARCINOEMBRYONIC ANTIGEN; FEMALE; HUMANS; LEPTIN; LYMPHATIC METASTASIS; MIDDLE AGED; MUCIN-1; POSTMENOPAUSE; PREMENOPAUSE; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 77954420709     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-432.
2. Collins S, Kuhn CM, Petro AE, Swick AG, Chrunyk BA, Surwit RS. Role of leptin in fat regulation. Nature 1996; 380: 677.
3. Lindheim SR, Sauer MV, Carmina E, Chang PL, Zimmerman R, Lobo RA. Circulating leptin levels during ovulation induction: relation to adiposity and ovarian morphology. Fertil Steril 2000; 73: 493-498.
4. Considine RV, Sinha MK, Heiman ML et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292-295.
5. McGregor GP, Desaga JF, Ehlenz K et al. Radioimmunological measurement of leptin in plasma of obese and diabetic human subjects. Endocrinology 1996; 137: 1501-1504. (Pubitemid 26098620)
6. Sinha MK, Opentanova I, Ohannesian JP et al. Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short-term fasting. J Clin Invest 1996; 98: 1277-1282. (Pubitemid 26322051)
7. Konopleva M, Mikhail A, Estrov Z et al. Expression and function of leptin receptor isoforms in myeloid leukemia and myelodysplastic syndromes: proliferative and anti-apoptotic activities. Blood 1999; 93: 1668-1676.
8. Sierra-Honigmann MR, Nath AK, Murakami C et al. Biological action of leptin as an angiogenic factor. Science 1998; 281: 1683-1686. (Pubitemid 28435586)
9. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004; 4: 579-591. (Pubitemid 39025053)
10. Ursin G, Longnecker MP, Haile RW, Greenland SA. Meta-analysis ofbody mass index and risk of premenopausal breast cancer. Epidemiology 1995; 6: 137-141.
11. Calle EE, Thun MJ. Obesity and cancer. Oncogene 2004; 23: 6365-6378.
12. Simons PJ, Annemie MWJ, Schols L, Campfield A, Emiel FMW, Saris WH. Plasma concentration of total leptin and human lung cancer-associated cachexia. Clin Sci 1997; 93: 273-277. (Pubitemid 27387066)
13. Stattin P, Soderberg S, Hallmans G et al. Leptin is associated with increased prostate cancer risk: a nested case-referent study. J Clin Endocrinol Metab 2001; 86; 1341-1345. (Pubitemid 32323026)
14. Neville MC, McFadden TB, Forsyth I. Hormonal regulation of mammary differentiation and milk secretion. J Mammary Gland Biol Neoplasia 2002; 7: 49-66. (Pubitemid 38420781)
15. Garofalo C, Surmacz E. Leptin and cancer. J Cell Physiol 2006; 207: 12-22.
16. Tessitore L, Vizio B. Leptin: a novel marker for breast cancer progression. In: Proceed 2nd Congress of Balkan Union of Oncology, Izmir, 1998; 163-167.
17. Tessitore L, Vizio B, Pesola D et al. Adipocyte expression and circulating levels of leptin increase in both gynaecological and breast cancer patients. Int J Oncol 2004; 24: 1529-1535.
18. Tessitore L, Vizio B, Jenkins O et al. Leptin expression in colorectal and breast cancer patients. Int J Mol Med 2000; 5: 421-426.
19. Ishikawa M, Kitayama J, Nagawa H. Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin Cancer Res 2004; 10: 4325-4331. (Pubitemid 38878870)
20. Garofalo C, Koda M, Cascio S et al. Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesity-related stimuli. Clin Cancer Res 2006; 12: 1447-1453.
21. Miyoshi Y, Funahashi T, Tanaka S et al. High expression of leptin receptor mRNA in breast cancer tissue predicts poor prognosis for patients with high, but not low, serum leptin levels. Int J Cancer 2006; 118: 1414-1419. (Pubitemid 43306527)
22. Revillion F, Charlier M, Lhotellier V et al. Messenger RNA expression of leptin and leptin receptors and their prognostic value in 322 human primary breast cancers. Clin Cancer Res 2006; 12: 2088-2094.
23. Woodward WA, Strom EA, Tucker SL et al. Changes in the 2003 American Joint Committee on Cancer staging for breast cancer dramatically affect stage-specific survival. J Clin Oncol 2003; 21: 4467-4468.
24. Hou MF, Lin SB, Yuan SS et al. The clinical significance between activation of nuclear factor kappa B transcription factor and overexpression of HER-2/neu oncoprotein in Taiwanese patients with breast cancer. Clin Chim Acta 2003; 334: 137-144.
25. Marshak DR (Ed). Strategies for protein purification and characterization: a laboratory course manual. Cold Spring Harbor Laboratory Press, Plainview, NY, 1996.
26. Peto J. Cancer epidemiology in the last century and the next decade. Nature 2001; 411: 390-395. (Pubitemid 32467050)
27. Willett WC. Fat, energy and breast cancer. J Nutr 1997; 127: 921S-923S.
28. Ozet A, Arpaci F, Yilmaz Ilker M et al. Effects of tamoxifen on the serum leptin level in patients with breast cancer. Jpn J Clin Oncol 2001; 31: 424-427. (Pubitemid 33039749)
29. Okumura M, Yamamoto M, Sakuma T et al. Leptin and high glucose stimulate cell proliferation in MCF-7 human breast cancer cells: reciprocal involvement of PKC-α and PPAR expression. Biochim Biophys Acta 2002; 1592: 107-116.
30. Pickup JC, Chusney GD, Mattock MB. The innate immune response and type 2 diabetes: evidence that leptin is associated with a stress-related reaction. Clin Endocrinol 2000; 52: 107-112.
31. Matarese G, Sanna V, Lechler RI et al. Leptin accelerates autoimmune diabetes in female NOD mice. Diabetes 2002; 51: 1356-1361. (Pubitemid 34826599)